flow to ischemic tissues (4) (5) (6) (7) . Indeed, it has been demonstrated in the clinical setting that a welldeveloped collateral artery network due to efficient arteriogenesis in principle has the ability to compensate even for the complete occlusion of large arteries in humans (6, 10 To achieve this goal, in a first step, decellularized ECM were prepared from porcine skeletal muscle tissue and human umbilical cords and further processed to yield a purified, pepsin-digested lyophilisate that, before its use, was converted to an isotonic injectable hydrogel by the addition of sterile water. A thorough characterization of these hydrogels involving, for example, global proteomics as well as scanning electron microscopy analyses performed upon gelation of these hydrogels in vivo revealed considerable differences in the molecular composition and mesh-like macrostructures of both matrices, that is, a more close-meshed and regular structure of the ECM-based hydrogel derived from porcine skeletal muscle tissue. Thus, the present study supports the current perception that ECM compositions considerably depend on the tissue studied and that biomaterials derived hereof, at least in part, retain the biomechanical and biochemical characteristics of their original tissue source (12, 13) .
In a subsequent set of in vivo experiments, the impact of both hydrogel preparations on arterial blood flow recovery and blood vessel growth was analyzed in a rat hindlimb ischemia model after a single bolus injection of the biomaterial into the ischemic gracilis muscle 7 days after femoral artery ligation. In this experimental setup, perfusion of both ischemic and healthy limbs was regularly analyzed over a period of 6 weeks before and after the intervention. Most importantly, within 3 weeks after injection, both hydrogel preparations, to a similar extent, improved arterial blood flow to the ischemic muscle tissue as compared with control interventions, and this effect remained stable (or even further increased) during the remaining 2 weeks of the study. Additional morphometric analyses showed a higher density of large arterioles, but no change in the density of capillaries in the affected muscle tissue of hydrogel-treated animals. These findings led the authors to conclude that the (comparable) increase in blood flow induced by both hydrogels depended on the induction of arteriogenesis rather than angiogenesis, a conclusion that is supported by the existing literature in that: 1) development of a functional collateral circulation induces a significant shift towards an increase in arteriolar vessel size rather than an increase in arteriolar or capillary vessel density (6,10); and 2) arteriogenesis is the most prominent mechanism for blood flow recovery after femoral artery occlusion at least in small rodent models (6, 10, 14) . However, the fact that similar arteriogenic effects were observed during treatment with the 2 hydrogels from different tissue sources indicates that a common (and still unknown) ECM-derived stimulus rather than tissue-specific ECM cues were necessary to promote arteriogenesis in this model. In further histological analyses, the authors additionally focused on the ability of hydrogels to confer tissue (skeletal muscle) protection. Interestingly, in this setting skeletal muscle-derived hydrogels more strongly improved skeletal muscle progenitor recruitment and muscle architecture, thereby suggesting that skeletal muscle-derived ECM provides specific signals to foster skeletal muscle integrity during tissue ischemia.
Although the study contributes several valuable findings to the field of arteriogenesis research, it also has certain limitations. In this regard, one obvious limitation of the present study is that it cannot provide a conclusive explanation for its key observations, namely the proarteriogenic properties of acellular ECM-based hydrogels. In an attempt to fill the mechanistic gap, whole transcriptome data were captured in ischemic muscle tissue from hydrogeltreated and control mice 3 and 10 days after intervention. These analyses yielded 2 "hard-to-interpret" sets of transcriptome data that showed 561 differentially regulated genes early after intervention, whereas the number of differentially regulated genes 
